Mylan Hit With GMP Warning Letter Despite Quality Improvement Efforts
FDA issues 14-page letter citing GMP violations at three Mylan plants; company has halted production and distribution at one of the facilities.
FDA issues 14-page letter citing GMP violations at three Mylan plants; company has halted production and distribution at one of the facilities.